Bone Marrow Transplant. 2013 Jan;48(1):63-7. Appelbaum FR, Anasetti C, Antin JH, Atkins H, Davies S, Devine S, Giralt S, Heslop H, Laport G, Lee SJ, Logan B, Pasquini M, Pulsipher M, Stadtmauer E, Wingard JR, Horowitz MM. Blood and marrow transplant clinical trials community state of the Science Symposium 2014. Biol Blood Marrow Transplant. Juliusson G, Lazarevic V, Horstedt AS, Hagberg O, Hoglund M; Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the actual world: why inhabitants-based registries are needed. Mrozek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, Pettenati MJ, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Stone RM, Larson RA, Bloomfield CD. Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. Burnett AK, Russell NH, Hills RK, Kell J, Nielsen OJ, Dennis M, Cahalin P, Pocock C, Ali S, Burns S, Freeman S, Milligan D, Clark RE.
Biol Blood Marrow Transplant. Kasamon YL, Bolanos-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, Rosner GL, Brodsky RA, Perica K, Smith BD, Gladstone DE, Swinnen LJ, Showel MM, Matsui WH, Huff CA, Borrello I, Pratz KW, McDevitt MA, Gojo I, Dezern AE, Shanbhag S, Levis MJ, Luznik L, Ambinder RF, Fuchs EJ, Jones RJ. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. 70 Years. Biol Blood Marrow Transplant. Basak GW, Sánchez-Ortega I, Beohou E, et al. Allogeneic Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT. Soto-Perez-de-Celis E, Li D, Yuan Y, Lau YM, Hurria A. Functional versus chronological age: geriatric assessments to information decision making in older patients with cancer. Lancet Oncol. 2018 Jun;19(6):e305-e316. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new technique of classifying prognostic comorbidity in longitudinal studies: development and validation.
Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new software for RISK ASSESSMENT MODEL RISK ASSESSMENT PLAN before allogeneic HCT. Sorror ML, Logan BR, Zhu X, Rizzo JD, Cooke KR, McCarthy PL, Ho VT, Horowitz MM, Pasquini MC. Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant. Raimondi R, Tosetto A, Oneto R, Cavazzina R, Rodeghiero F, Bacigalupo A, Fanin R, Rambaldi A, Bosi A. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a potential, multicenter GITMO examine. Sorror ML, Storb RF, Sandmaier BM, Maziarz RT, Pulsipher MA, Maris MB, Bhatia S, Ostronoff F, Deeg HJ, Syrjala KL, Estey E, Maloney DG, Appelbaum FR, Martin PJ, Storer BE. Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation. Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA, Kline J, Liu H, Odenike OM, Larson RA, van Besien K, Artz AS.
2 Consultant, DABMEB Consultancy Ltd., Sharnbrook, UK. Three Member Idea Supervisory Group, University of Surrey, Guildford, UK. Four Consultant, Geneva, Switzerland. 5 Firmenich SA, 1 Route des Jeunes, Geneva, Switzerland. 6 Unilever Safety & Environmental Assurance Centre, Sharnbrook, UK. 7 Member Idea Supervisory Group, Technical University of Munich, Germany. When you have just about any concerns with regards to where and also how you can employ RISK ASSESSMENT RECORD KEEPING, you are able to email us in our web-page. Eight Symrise AG, Holzminden, Germany. 9 NV Procter & Gamble Services Company SA, Strombeek-Bever, Belgium. 10 Member Idea Supervisory Group, Cosmetics Consultant, Singapore. 11 Creme Global, Dublin, Ireland. 12 Member Idea Supervisory Group, VU Amsterdam, Netherlands. Thirteen The Procter & Gamble Company, Mason, OH, USA. 14 Consultant, B-Safe Toxicology Consulting, Rushden, UK. 15 Innovations in Food and Chemical Safety Programme, Singapore Institute of Food & Biotechnology Innovation, Agency for Science, Technology & Research, Singapore; School of Chemical & Biomedical Engineering, Nanyang Technological University, Singapore. 16 International Fragrance Association, Brussels, Belgium. 17 Member Idea Supervisory Group, St. John's Institute of Dermatology, London, UK. 1 Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.
